515 filings
Page 6 of 26
CORRESP
40klmxyanme0exhbj
21 Mar 18
Correspondence with SEC
12:00am
3
u63mzkky30x
16 Mar 18
GT Biopharma / Shawn Cross ownership change
12:00am
8-K/A
xua vzi4ibgpthd
15 Mar 18
Amendments to Articles of Incorporation or Bylaws
12:00am
CORRESP
kt4ead67 c1
15 Mar 18
Correspondence with SEC
12:00am
UPLOAD
ln13476fkkyd2egcpt
12 Mar 18
Letter from SEC
12:00am
UPLOAD
jjzhh8
12 Mar 18
Letter from SEC
12:00am
8-K
kmpwjdbw9618ha95v2t
21 Feb 18
Entry into a Material Definitive Agreement
12:00am
SC 13G/A
9mj fr9ta
7 Feb 18
GT Biopharma, Inc.
12:00am
D
teevv1uuj3v9qs
6 Feb 18
$7.06M in debt / options, sold $7.06M, 14 investors
12:00am
8-K
fmwodx
23 Jan 18
Entry into a Material Definitive Agreement
12:00am